Immunobiology of Human Mesenchymal Stem Cells and Future Use in Hematopoietic Stem Cell TransplantationKatarina Le Blanc, Olle Ringdén|Biology of Blood and Marrow Transplantation|2005Cited by 481
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant ResearchSally Arai, Yoshiko Atsuta, Mary E.D. Flowers et al.|Biology of Blood and Marrow Transplantation|2014Cited by 435
Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?Guido Moll, Katarina Le Blanc, Ida Rasmusson-Duprez et al.|Stem Cells|2012Cited by 371
Second Solid Cancers after Allogeneic Hematopoietic Cell Transplantation Using Reduced-Intensity ConditioningOlle Ringdén, Navneet S. Majhail, Ruta Brazauskas et al.|Biology of Blood and Marrow Transplantation|2014Cited by 67
Comparative Analysis of Calcineurin Inhibitor–Based Methotrexate and Mycophenolate Mofetil–Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic TransplantationSaurabh Chhabra, Betty K. Hamilton, Ying Liu et al.|Biology of Blood and Marrow Transplantation|2018Cited by 51